We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

67 hedge funds and large institutions have $290M invested in Arcus Biosciences in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 13

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

18% more funds holding

Funds holding: 57 → 67 (+10)

10.09% more ownership

Funds ownership: 50.47% → 60.56% (+10%)

7% less capital invested

Capital invested by funds: $313M → $290M (-$22.9M)

Holders
67
Holders Change
+10
Holders Change %
+17.54%
% of All Funds
1.49%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
20
Increased
27
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BI
BVF Inc
California
+$15.8M
2
BlackRock
BlackRock
New York
+$15M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.73M
4
State Street
State Street
Massachusetts
+$4.91M
5
Northern Trust
Northern Trust
Illinois
+$2.32M

Top Sellers

1
FCMI
Foresite Capital Management III
California
-$16.5M
2
EC
EcoR1 Capital
California
-$11.8M
3
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$6.26M
4
PHS
PFM Health Sciences
California
-$5.87M
5
HIM
Hillhouse Investment Management
Cayman Islands
-$4.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
QSS
51
Quantitative Systematic Strategies
Florida
$116K +$126K +10,759 New
AllianceBernstein
52
AllianceBernstein
Tennessee
$116K +$126K +10,800 New
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$68K – – –
Legal & General Group
54
Legal & General Group
United Kingdom
$62K +$51.4K +4,404 +311%
Canada Life
55
Canada Life
Manitoba, Canada
$51K +$57.9K +4,956 New
Federated Hermes
56
Federated Hermes
Pennsylvania
$40K -$2.71K -232 -6%
AIP
57
Ameritas Investment Partners
Nebraska
$27K +$24.5K +2,100 +486%
US Bancorp
58
US Bancorp
Minnesota
$25K +$1.4K +120 +6%
Barclays
59
Barclays
United Kingdom
$17K -$47K -4,026 -72%
PIM
60
Partner Investment Management
California
$17K -$41.9K -3,586 -69%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$11K -$4.23K -362 -27%
IUHSA
62
Itau Unibanco Holding S.A.
Brazil
$9K -$1.35K -116 -12%
LTFS
63
Ladenburg Thalmann Financial Services
Florida
$9K – – –
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$5K +$4.46K +382 +597%
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
$3.46K +$1.77K +152 +90%
APA
66
American Portfolios Advisors
New York
$2.69K +$2.92K +250 New
BOTOTLSJU
67
Board of Trustees of The Leland Stanford Junior University
California
– -$6.26M -448,862 Closed
Lord, Abbett & Co
68
Lord, Abbett & Co
New Jersey
– -$4.24M -304,343 Closed
FCMI
69
Foresite Capital Management IV
California
– -$4.11M -295,000 Closed
VIA
70
Vident Investment Advisory
Georgia
– -$2.04M -146,384 Closed
Millennium Management
71
Millennium Management
New York
– -$1.97M -141,077 Closed
Fidelity International
72
Fidelity International
Bermuda
– -$743K -53,286 Closed
VEA
73
Virtus ETF Advisers
New York
– -$400K -28,669 Closed
JC
74
JBF Capital
Colorado
– -$80K -5,712 Closed
CPIG
75
Chicago Partners Investment Group
Illinois
– -$1K -150 Closed
1 2
3
4

RCUS Hedge Fund Activity: Q4 2018 in Review

67 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q4 2018, worth a combined $290M — down 7.3% from $313M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new RCUS positions and 10 closed out — a net gain of 10 holders — while 27 added to existing stakes and 13 trimmed.

The largest buyer was BVF Inc, adding an estimated $15.8M. The largest seller was Foresite Capital Management III, cutting an estimated $16.5M.

  • 67 institutional investors held Arcus Biosciences (RCUS) as of Q4 2018, up from 57 in Q3 2018.
  • Funds reported $290M of Arcus Biosciences stock for Q4 2018, down 7.3% quarter-over-quarter.
  • 20 funds opened new Arcus Biosciences positions in Q4 2018 and 10 closed out, a net change of +10 holders.
  • The largest Arcus Biosciences buyer in Q4 2018 was BVF Inc, an estimated $15.8M added.
  • The largest Arcus Biosciences seller in Q4 2018 was Foresite Capital Management III, an estimated $16.5M sold.

Based on aggregated 13F filings for Q4 2018.